Benedict Osorio

Manufactures and sells drug products

Manufactures and markets medicines for prostate cancer

Operates as a biopharmaceutical company that develops, manufactures and markets therapeutic products for neurological disorders

Discovers, develops and commercializes treatments for infectious diseases

Distributes medicines

Functions as a College/University

Engages in promoting and advancing quality tools, principles and practices in their workplaces & communities

Part of Purdue Pharma LP, The PF Laboratories, Inc. is a pharmaceutical company that develops, manufactures, and markets prescription and consumer health medications. The company is based in Totowa, NJ. The company’s product portfolio includes opioid analgesics such as Butrans (buprenorphine), Hysingla ER (hydrocodone), and OxyContin (oxycodone), as well as other prescription and non-prescription medicines. It provides comprehensive prescribing information, safety data, and FDA-mandated risk evaluation and mitigation strategies to educate healthcare providers and patients on safe opioid administration. The company supports public health initiatives addressing the opioid crisis, including research on opioid overdose reversal agents like nalmefene hydrochloride injection, and offers expanded access programs for investigational medicines to patients with serious conditions lacking alternatives. Purdue Pharma also engages in corporate social responsibility through community partnerships, grants, volunteerism, and patient savings programs to improve access to treatments. The company maintains a focus on ethics, compliance, privacy, and transparency, and continues operations amid restructuring efforts with plans to emerge as Knoa Pharma. Purdue Pharma fosters collaborative research to advance treatments for pain, cancer, and central nervous system disorders.

Develops, manufactures, and markets pharmaceutical products